Lukas Biomedical (ROCO:6814) Long-Term Debt : NT$64.20 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Lukas Biomedical Long-Term Debt?

Lukas Biomedical's Long-Term Debt for the quarter that ended in Jun. 2024 was NT$64.20 Mil.

Lukas Biomedical's quarterly Long-Term Debt declined from Dec. 2022 (NT$57.53 Mil) to Jun. 2023 (NT$54.33 Mil) but then increased from Jun. 2023 (NT$54.33 Mil) to Jun. 2024 (NT$64.20 Mil).

Lukas Biomedical's annual Long-Term Debt declined from Dec. 2020 (NT$70.21 Mil) to Dec. 2021 (NT$63.82 Mil) and declined from Dec. 2021 (NT$63.82 Mil) to Dec. 2022 (NT$57.53 Mil).

Lukas Biomedical Long-Term Debt Historical Data

The historical data trend for Lukas Biomedical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lukas Biomedical Long-Term Debt Chart

Lukas Biomedical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Debt

81.89

73.91

70.21

63.82

57.53

Lukas Biomedical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Jun24
Long-Term Debt	Get a 7-Day Free Trial						63.82	60.67	57.53	54.33	64.20

Lukas Biomedical (ROCO:6814) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Lukas Biomedical Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xinyi Road, Da'an District, 3rd Floor, No. 2, Lane 265, Section 4, Taipei, TWN

Website

https://www.lukas-bio.com.tw

Lukas Biomedical Inc is engaged in the research and development of immunotherapy for cancer treatment technologies. It researches on the Memory T cell (LuLym-T) to improve the clinical outcome of cancer treatment.

Lukas Biomedical Headlines

No Headlines